SEC Tracker
Get the app

Cadrenal Therapeutics CVKD

Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Cadrenal Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Lexaria Bioscience LEXX public float $25M, Feb 28, 2025, over 18 months old
  2. Scynexis SCYX public float $26M, Jun 30, 2025
  3. Palatin Technologies PTN public float $26M, Dec 31, 2025
  4. Aytu Biopharma AYTU public float $24M, Dec 31, 2025
  5. Tenax Therapeutics TENX public float $24M, Jun 30, 2025